FIBROBIOLOGICS INC. - COMMON STOCK

FibroBiologics Presenting at the ThymUS 2025 Meeting

29 апр 2025 08:15:00 Источник Nasdaq GlobeNewswire

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

11 апр 2025 07:30:00 Источник Nasdaq GlobeNewswire

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

08 апр 2025 07:30:00 Источник Nasdaq GlobeNewswire

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

02 апр 2025 07:30:00 Источник Nasdaq GlobeNewswire

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

31 мар 2025 15:25:00 Источник Nasdaq GlobeNewswire

FibroBiologics Announces 2025 Annual Meeting of Stockholders

27 мар 2025 07:30:00 Источник Nasdaq GlobeNewswire

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

21 мар 2025 07:30:00 Источник Nasdaq GlobeNewswire

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

04 мар 2025 07:30:00 Источник Nasdaq GlobeNewswire

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

27 фев 2025 07:30:00 Источник Nasdaq GlobeNewswire

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

05 фев 2025 08:15:00 Источник Nasdaq GlobeNewswire

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

30 дек 2024 15:30:00 Источник Nasdaq GlobeNewswire

FibroBiologics Announces $25 Million Financing

23 дек 2024 06:55:00 Источник Nasdaq GlobeNewswire

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

19 ноя 2024 08:15:00 Источник Nasdaq GlobeNewswire

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

14 ноя 2024 08:15:00 Источник Nasdaq GlobeNewswire

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

12 ноя 2024 15:20:00 Источник Nasdaq GlobeNewswire

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

29 окт 2024 08:15:00 Источник Nasdaq GlobeNewswire

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

28 окт 2024 08:31:00 Источник Nasdaq GlobeNewswire

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

18 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

16 окт 2024 08:15:00 Источник Nasdaq GlobeNewswire

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

11 окт 2024 08:31:00 Источник Nasdaq GlobeNewswire